Heart bypass patients: could colchicine lower your risk of a dangerous irregular heartbeat?
NCT ID NCT07287345
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This study tests whether colchicine, a medicine used for gout, can reduce inflammation and lower the chance of developing atrial fibrillation (an irregular heartbeat) after heart bypass surgery. About 24 adults scheduled for bypass surgery will be randomly assigned to receive either colchicine or a placebo, along with standard care. Researchers will track inflammation markers and heart rhythm for 10 days after surgery to see if colchicine helps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLCHICINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Kentucy
RECRUITINGLexington, Kentucky, 40536, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.